The Convergence Signal: Two Nutrition Markets. One Unclaimed Edge.
Why a Feeding Tube and a Wearable Biosensor are Telling the Same Story Imagine two people, one recovering from surgery and the other a wellness-forward executive wearing a biosensor. The person recovering from surgery is fed from a tube as an AI model quietly tailors calorie, fluid, and protein intake in real time based on […]
Recovery: The Next Competitive Currency in Sports Medicine
Is Recovery the New Finishing Line in Sports Medicine? Earlier, the operating table was the prime parameter of sports medicine leadership. However, that measure no longer works. Patients are not just about efficiency but also about speed. Payers, too, expect proof before paying. Balancing these two demands is giving rise to a market that prioritizes […]
Future of Sports Medicine: Competing for Recovery Ecosystem Leadership
Executive Summary With the sports medicine market slated to cross $15 billion in the next few years, it is important to understand how competition dynamics will change in the next decade. For starters, it wouldn’t be a single breakthrough, but an ability to integrate wearables, digital rehabilitation, AI, and biologics into a single recovery ecosystem. […]
The Recovery Economy: How Expectations Are Shifting Across the Sports Medicine Ecosystem
Executive Summary For sports medicine manufacturers, the need to move beyond implant performance has never been higher. They must build integrated recovery systems that offer decision support and continuous visibility across the patient’s journey. Marketing efforts must move away from speed-focused claims and center the narrative on predictable, safe, and complete recovery. Clinics and hospitals […]
Winning the Recovery Race: How Sports Medicine Companies are Repositioning for Outcome-Driven Care
Executive Summary: The sports medicine market is undergoing a pivotal shift. It is moving from procedure-focused innovation to owning the future recovery journey. The growing pressure of more predictable, faster outcomes from evolving patient and value-based care expectations is further pushing companies to expand their portfolios beyond implants. The new add-ons now include digital rehabilitation, […]
Turning Blind Spots into Readiness: Scaling Sensor-Enabled Spine Implants
Structural Implant to Data Production: The Expectation and the Contradiction Sensor-based spine devices hold the potential to revolutionize structural hardware as a continuous source of clinical intelligence. However, the majority of such programs never make it past the initial stages. The issue is not about whether the devices can provide data, but whether the organization […]
Neurotherapeutics: The Next Wave
The Post-SSRI Transition: Evidence, Capital, and the Rapidly Closing Window In the neurotherapeutics sector, molecules were never the problem; strategy was. To elaborate on this premise, we brought three distinct evolving concepts together: the slowly crumbling SSRI paradigm, psychedelic compounds joining the clinical mainstream, and a closer look at the psilocybin landscape. The clinical picture […]
Bridging Innovation and Scalable Impact in Surgical Robotics
The Inflection Point: From Hardware Sales to Value Ecosystems Surgical robotics has reached a crucial milestone. Once considered luxury prestige technologies, robotic platforms are now being seen as essential hospital infrastructure by hospitals worldwide. As the market is expected to grow, it will be business model innovation, not technological advances, that determines which companies dominate […]
Reinventing Relevance: Five Levers for MedTech OEMs in the Era of Decentralized Diagnostics
Competing in this new landscape will require pragmatic approach, beyond mergers, acquisitions, startup acceleration, or technology additions. It calls for a rethinking of how these companies operate, how they create, deliver, and sustain value in a system that’s no longer centred on the lab. Part 1 of this article discussed a business hypothesis and a […]
The Strategic Shift from B2H to At-Home Care
The surgical procedure may end at discharge. The economics of that procedure do not. Surgical care is undergoing a structural shift. Value-based payments, GPO consolidation, growing Medicare and Medicaid enrollment, and the migration of procedures to ASCs are pressuring hospitals to reduce length of stay, complications, and total episode costs. These pressures are now extending […]